Tag: ACE 64
“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute...
Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...
Penumbra launches ACE 68 reperfusion catheter in USA
Penumbra has launched its new ACE 68 reperfusion catheter in the USA. The catheter is part of the Penumbra System, and was launched at...
Long-term experience confirms ADAPT as effective treatment for stroke
A study of the long-term use of the ADAPT technique for the treatment of acute ischaemic stroke has confirmed that it is an efficient...
ADAPT to the Challenges of Stroke
Acute ischaemic stroke is the second most common cause of death and disability in Europe. The evidence in the recently published or presented randomised...
ACE64 study demonstrates high revascularisation rates, quick procedure times
Penumbra has announced that the results of the European multicentre study of the company’s ACE64 thrombectomy system were presented in the Abstract Presentations Session at...
FDA clears Penumbra ACE64 for acute ischaemic stroke patients
Penumbra has announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the US Food and Drug Administration for the revascularisation...
